These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38754983)

  • 21. Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
    Liu Q; Zaba LC; Satpathy AT; Longmire M; Zhang W; Li K; Granja J; Guo C; Lin J; Li R; Tolentino K; Kania G; Distler O; Fiorentino D; Chung L; Qu K; Chang HY
    Nat Commun; 2020 Nov; 11(1):5843. PubMed ID: 33203843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
    Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
    Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
    Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosis.
    Tirelli F; Pachera E; Gmür S; Lafyatis R; Huang M; Zulian F; Camarillo Retamosa E; Kania G; Distler O
    Rheumatology (Oxford); 2024 Oct; 63(10):2846-2855. PubMed ID: 38305495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
    Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
    Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
    Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.
    Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
    Taniguchi T; Miyagawa T; Tamaki Z; Nakamura K; Yamashita T; Saigusa R; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Tada Y; Sugaya M; Kadono T; Sato S; Asano Y
    Arch Dermatol Res; 2017 Dec; 309(10):833-842. PubMed ID: 29038846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myofibroblast transcriptome indicates SFRP2
    Tabib T; Huang M; Morse N; Papazoglou A; Behera R; Jia M; Bulik M; Monier DE; Benos PV; Chen W; Domsic R; Lafyatis R
    Nat Commun; 2021 Jul; 12(1):4384. PubMed ID: 34282151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.
    Kanno Y; Shu E; Kanoh H; Matsuda A; Seishima M
    Arthritis Res Ther; 2017 Feb; 19(1):22. PubMed ID: 28159016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis.
    Cipriani P; Ruscitti P; Di Cola I; Vomero M; Abbruzzese F; Di Nino E; Ross R; Del Galdo F; Giacomelli R
    Rheumatology (Oxford); 2023 Mar; 62(3):1317-1325. PubMed ID: 35916713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.
    Takahashi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Toyama T; Taniguchi T; Yoshizaki A; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2016 Dec; 175(6):1195-1203. PubMed ID: 27105895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
    Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
    Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
    Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
    Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
    J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.